Singulair Oral Tablet 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Singulair: Oral tablet (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_16563.JPG
Singulair 10mg Tab
Merck Sharp & Dohme Corp., a Subsidiary of Merck & Co., Inc.
Pill Identification: MSD 117  |  SINGULAIR
Drug Image file DrugItem_7138.JPG
Singulair 10mg Tab
Merck Sharp & Dohme Corp., a Subsidiary of Merck & Co., Inc.
Pill Identification: MRK 117  |  SINGULAIR

What is this Medicine?

MONTELUKAST (mon te LOO kast) is used to prevent and treat the symptoms of asthma. It is also used to treat allergies. Do not use for an acute asthma attack.

CVS Pharmacy Patient Statistics for Singulair: Oral tablet(10mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Singulair 10mg Tablet

NDC: 000069117
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Allergic Rhinitis, Exercise-induced Bronchospasm Prophylaxis, Asthma

Sometimes used for but not FDA approved for the following conditions:
Urticaria, Aspirin-induced Asthma, Chronic Idiopathic Urticaria, Atopic Dermatitis

Storage Information
Protect from light
Store in original container
Protect from moisture
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Singulair 10mg Tablet
Drug Image file DrugItem_16563.JPG
Merck Sharp & Dohme Corp., a Subsidiary of Merck & Co., Inc.
Pill Identification: MSD 117  |  SINGULAIR
Shape: square
Color: beige

Reported Side Effects for Singulair 10mg Tablet

Headache Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Sinus Infection Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Pus In Urine Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Nose Bleed Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
>1.5%*
Severity: MILD
Onset: EARLY
Stuffy Nose Incidence:
1.6%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
>1.6%*
Severity: MILD
Onset: EARLY
Tired Incidence:
1.8%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
1.8%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
>1.9%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
1.9%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Wheezing Incidence:
>2.0%*
Severity: MODERATE
Onset: RAPID
Nearsightedness Incidence:
>2.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Stomach Incidence:
>2.0%*
Severity: MODERATE
Onset: DELAYED
Hives Incidence:
>2.0%*
Severity: MILD
Onset: RAPID
Rhinitis Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Scaly And Itchy Rashes Incidence:
>2.0%*
Severity: MODERATE
Onset: DELAYED
Conjunctivitis Incidence:
>2.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Runny Nose Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Inflamed Vocal Cords Incidence:
>2.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
>2.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Flu Incidence:
>2.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Singulair

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5